Adobe may need narrative change to fire stock higher

Reaction suggests investors may no longer swayed by earnings ‘beats’

In rude health: AstraZeneca, Britain’s biggest drugmaker, has “risen to the challenge” of US healthcare providers negotiating drug prices by posting “solid first-half sales growth”, says Derren Nathan

Who’s tipping what The week’s best shares ...

Investors should consider shifting their focus to ‘old economy’ stocks rather than technology

UK equities are having their time in the sun. The FTSE 100 recently hit an all-time high of 9,000, driven by a broad recovery in equity prices. To put it another way, the rally wasn’t just driven by a

Growth should re-accelerate at this Iberian fashion giant with a fortress balance sheet